Complete financial analysis of Body and Mind Inc. (BMMJ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Body and Mind Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Hi-Lai Foods Co., Ltd (1268.TWO) Income Statement Analysis – Financial Results
- Sandfire Resources Limited (SFRRF) Income Statement Analysis – Financial Results
- Twenty – Four Con & Supply Public Company Limited (24CS.BK) Income Statement Analysis – Financial Results
- Indag Rubber Limited (INDAG.BO) Income Statement Analysis – Financial Results
- Ebang International Holdings Inc. (EBON) Income Statement Analysis – Financial Results
Body and Mind Inc. (BMMJ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.bodyandmind.com
About Body and Mind Inc.
Body and Mind Inc. cultivates, processes, distributes, and retails medical and recreational cannabis in Nevada, California, Arkansas, Ohio, and Michigan in the United States. The company offers packaged and grinded flower buds; concentrates; Gpen vaporizers; distillate oil cartridges; and distillate infused edible products. It also produces and sells medical and adultuse recreational marijuana products, such as cannabis flower, oil, extracts, and edibles under the Body and Mind brand name. In addition, the company operates ShowGrow San Diego dispensary; and manages ShowGrow Long Beach dispensary. Further, it produces marijuana extract products, such as distillate oils, ice waxes, dry sifts, shatters, edibles, and topicals. The company was formerly known as Deploy Technologies Inc. and changed its name to Body and Mind Inc. in November 2017. Body and Mind Inc. was incorporated in 1998 and is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.82M | 31.64M | 25.70M | 5.29M | 4.61M | 2.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 17.04M | 20.69M | 13.71M | 3.78M | 2.83M | 1.22M | 1.68K | 6.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.78M | 10.94M | 11.99M | 1.51M | 1.78M | 1.20M | -1.68K | -6.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 25.31% | 34.59% | 46.65% | 28.53% | 38.61% | 49.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 835.33K | 669.47K | 282.87K | 449.95K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 11.15M | 12.97M | 9.95M | 6.89M | 4.61M | 2.36M | 288.52K | 122.76K | 131.41K | 245.23K | 267.52K | 847.15K | 454.14K | 158.93K | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 669.47K | 282.87K | 449.95K | 0.00 | 0.00 | 49.11K | 1.06K | 0.00 | 23.54K | 38.68K | 11.31K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.15M | 12.97M | 9.95M | 6.89M | 4.61M | 2.36M | 372.12K | 126.11K | 131.41K | 268.77K | 306.21K | 915.09K | 454.14K | 158.93K | 87.50K | 0.00 |
| Other Expenses | 1.47M | 1.49M | 1.46M | 112.03K | 12.87K | 1.59K | 1.59K | 6.55K | 27.05K | 35.50K | 39.91K | 28.54K | 13.75K | 2.67K | 17.33K | 1.80K |
| Operating Expenses | 13.45M | 14.46M | 11.40M | 7.00M | 4.62M | 3.17M | 372.12K | 126.11K | 267.52K | 267.04K | 434.89K | 1.29M | 467.88K | 161.59K | 104.83K | 1.80K |
| Cost & Expenses | 30.49M | 35.16M | 25.11M | 10.78M | 7.45M | 4.38M | 373.80K | 132.78K | 267.52K | 267.04K | 434.89K | 1.29M | 467.88K | 161.59K | 104.83K | 1.80K |
| Interest Income | 72.00K | 72.00K | 163.56K | 1.12M | 719.87K | 5.62K | 0.00 | 0.00 | 0.00 | 76.00 | 0.00 | 14.00 | 27.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.72M | 1.37M | 53.39K | 132.72K | 1.24M | 5.62K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.00 | 4.07K | 2.12K | 78.00 | 0.00 |
| Depreciation & Amortization | 1.80M | 1.94M | 2.83M | 582.20K | 291.81K | 8.62K | 1.68K | 6.67K | 27.05K | 35.03K | 35.57K | 24.12K | 13.75K | 2.67K | 0.00 | 0.00 |
| EBITDA | -14.88M | -23.11M | 587.33K | -4.17M | -2.29M | -2.35M | -386.98K | -126.11K | -131.41K | -221.49K | -310.55K | -1.26M | -427.82K | -161.83K | -113.54K | -1.80K |
| EBITDA Ratio | -65.21% | -3.14% | 11.63% | -70.03% | -37.72% | -62.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -7.67M | -3.52M | 587.33K | -4.28M | -2.03M | -347.50K | -373.80K | -132.78K | -158.46K | -304.26K | -346.12K | -943.63K | -471.95K | -163.72K | -104.83K | -1.80K |
| Operating Income Ratio | -33.61% | -11.12% | 2.29% | -80.98% | -44.00% | -14.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -10.48M | -22.89M | -397.08K | 1.08M | -910.15K | -1.54M | -14.86K | 588.33K | -86.51K | 37.30K | -128.68K | -345.79K | 47.75K | -3.00K | -78.00 | 0.00 |
| Income Before Tax | -18.15M | -25.63M | 190.25K | -4.46M | -3.75M | -2.69M | -388.66K | 464.51K | -267.52K | -266.97K | -434.89K | -1.29M | -424.20K | 0.00 | -104.91K | -1.80K |
| Income Before Tax Ratio | -79.55% | -81.03% | 0.74% | -84.43% | -81.37% | -111.30% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 2.17M | 2.59M | 2.17M | 134.17K | 1.34M | -904.72K | -3.09 | -2.98 | 0.00 | 0.00 | 0.00 | 0.00 | 51.81K | 2.12K | 0.00 | 82.48K |
| Net Income | -20.78M | -28.23M | -1.98M | -4.60M | -5.09M | -1.78M | -388.66K | 464.51K | -267.52K | -266.97K | -434.89K | -1.29M | -424.17K | -163.72K | -104.91K | -84.28K |
| Net Income Ratio | -91.07% | -89.22% | -7.69% | -86.97% | -110.34% | -73.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.25 | -0.02 | -0.04 | -0.07 | -0.05 | -0.06 | 0.21 | -0.17 | -0.35 | -0.58 | -1.55 | -0.30 | -0.14 | -0.12 | -4.50 |
| EPS Diluted | -0.16 | -0.25 | -0.02 | -0.04 | -0.07 | -0.05 | -0.06 | 0.21 | -0.17 | -0.35 | -0.58 | -1.55 | -0.30 | -0.14 | -0.12 | -4.50 |
| Weighted Avg Shares Out | 134.35M | 112.21M | 108.46M | 102.64M | 69.55M | 38.93M | 6.38M | 2.19M | 1.54M | 764.69K | 744.32K | 830.00K | 1.40M | 1.21M | 857.18K | 18.71K |
| Weighted Avg Shares Out (Dil) | 134.35M | 112.21M | 108.46M | 102.64M | 69.55M | 38.93M | 6.38M | 2.19M | 1.54M | 764.69K | 744.32K | 830.00K | 1.40M | 1.21M | 857.18K | 18.71K |
Body and Mind Announces Fiscal Year End (July) 2023 Financial Results
Reports Annual Revenue of US$22.8 Million & Highlights Recent Developments Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - November 14, 2023) - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operations-focused cannabis company,...
Body and Mind Fully Repays Senior Secured Lender
Closes Ohio Dispensary Transaction Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - October 18, 2023) - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operations-focused cannabis company, is pleased to announce that the...
Body and Mind Highlights Recent Activities
Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - September 6, 2023) - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operations-focused cannabis company, is pleased to provide a corporate update, including the planned...
Body and Mind Announces Agreement to Divest Ohio Dispensary
Transaction Supports Balance Sheet Flexibility & Strategic Growth Initiatives Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - July 24, 2023) - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operations-focused cannabis company, is...
Where Is The Value In Cannabis Stocks?
Bengal Capital's Jerry Derevyanny moved away from top multi-state operators (MSOs) to find the most value. Why EBITDA falls short as a useful metric to measure cannabis stocks.
Body and Mind Inc. (BMMJ) CEO Michael Mills on Q3 2022 Results - Earnings Call Transcript
Call End: Body and Mind Inc. (OTCQB:BMMJ) Q3 2022 Earnings Conference Call June 21, 2021 05:00 PM ET Company Participants Graham Farrell - Investor Relations Michael Mills - Chief Executive Officer Trip Hoffman - Chief Operating Officer Conference Call Participants...
Body and Mind to Release Q2 Fiscal Results on March 17
LAS VEGAS and VANCOUVER, BC , March 15, 2022 /PRNewswire/ - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state US cannabis operator, is pleased to announce it intends to file results for the fiscal...
Cannabis Company Body And Mind Expands To Michigan
Body and Mind Inc. BAMM BMMJ announced completion of the first stage of the vertical strategy to expand into the rapidly growing Michigan market. This will be the fifth state with Body and Mind operations with additional wholly owned licenses...
Body and Mind's (BMMJ) CEO Michael Mills on Q4 2021 Results - Earnings Call Transcript
Body and Mind's (BMMJ) CEO Michael Mills on Q4 2021 Results - Earnings Call Transcript
Body and Mind Closes NMG Ohio Dispensary and Processing Facility Transaction
LAS VEGAS and VANCOUVER, BC, Sept. 17, 2021 /PRNewswire/ - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state operator focused on limited license markets, is pleased to report the closing of the acquisition of...
Source: https://incomestatements.info
Category: Stock Reports